Skip to main content
Livermore
Livermore
ZHEN

CASI Pharmaceuticals, Inc (DE)

CASIDelisted
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0000895051

CASI Pharmaceuticals, Inc (DE) was delisted in 2023; its insiders filed their last Form 4 on Sep 9, 2022; 23 institutions reported holding it in 13F filings for Q4 2022, worth $3.31M in total; no superinvestor held it.

13F holders, Q2 2021

Institutional positions in CASI Pharmaceuticals, Inc (DE) as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
69
−17 vs. Q1 2021
Shares held
46.7M
−6.41M (−12.1%) vs. Q1 2021
Total value
$72.3M
−$55.1M (−43.2%) vs. Q1 2021
New holders
17
14 more added
Sold out
34
23 more reduced

Compare with Q1 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting CASI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2021: 69 institutions
Q1 2021: 86 institutionsQ2 2021: 69 institutionsQ3 2021: 59 institutionsQ4 2021: 51 institutionsQ1 2022: 45 institutionsQ2 2022: 24 institutionsQ3 2022: 24 institutionsQ4 2022: 23 institutionsQ1 2023: 0 institutionsQ2 2023: 0 institutionsQ3 2023: 0 institutionsQ4 2023: 0 institutionsQ1 2024: 0 institutionsQ2 2024: 0 institutionsQ3 2024: 0 institutionsQ4 2024: 0 institutionsQ1 2025: 0 institutionsQ2 2025: 0 institutionsQ3 2025: 0 institutionsQ4 2025: 0 institutionsQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ2 2021: $72.3M
Q1 2021: $127.4MQ2 2021: $72.3MQ3 2021: $46.0MQ4 2021: $22.4MQ1 2022: $18.9MQ2 2022: $6.26MQ3 2022: $5.17MQ4 2022: $3.31MQ1 2023: $0Q2 2023: $0Q3 2023: $0Q4 2023: $0Q1 2024: $0Q2 2024: $0Q3 2024: $0Q4 2024: $0Q1 2025: $0Q2 2025: $0Q3 2025: $0Q4 2025: $0Q1 2026: $0Q2 2026: $0
Institutions holding CASI and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20250$0
Q3 20250$0
Q2 20250$0
Q1 20250$0
Q4 20240$0
Q3 20240$0
Q2 20240$0
Q1 20240$0
Q4 20230$0
Q3 20230$0
Q2 20230$0
Q1 20230$0
Q4 202223$3.31M
Q3 202224$5.17M
Q2 202224$6.26M
Q1 202245$18.9M
Q4 202151$22.4M
Q3 202159$46.0M
Q2 202169$72.3M
Q1 202186$127.4M

Institutions, Q2 2021

Shares, value and share of portfolio for each institution holding CASI Pharmaceuticals, Inc (DE); share changes are against Q1 2021.

Institutions holding CASI in Q2 2021
InstitutionSharesValue% of portfolioChange in sharesAction
FMR LLC0$00.00%−545−100.0%Sold out
Sowell Financial Services LLC0$00.00%−250−100.0%Sold out
RMR Wealth Builders0$00.00%−18−100.0%Sold out